Clinical Trials
58
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (55 trials with phase data)• Click on a phase to view related trials
A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy
- Conditions
- Vulvovaginal AtrophyMenopauseDyspareunia
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-02-02
- Last Posted Date
- 2017-08-23
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 203
- Registration Number
- NCT02670785
- Locations
- 🇺🇸
Visions Clinical Research-Tucson, Tucson, Arizona, United States
🇺🇸Genesis Center for Clinical Research, San Diego, California, United States
🇺🇸Coastal Connecticut Research, LLC, New London, Connecticut, United States
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
- First Posted Date
- 2013-09-11
- Last Posted Date
- 2015-06-29
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 796
- Registration Number
- NCT01939184
- Locations
- 🇺🇸
Warner Chilcott Investigational Study Site, Wauwatosa, Wisconsin, United States
🇺🇸Warner Chilcottt Investigational Study Site, Clearwater, Florida, United States
Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia
- Conditions
- Vulvovaginal Atrophy
- Interventions
- Drug: WC3011 Estradiol Vaginal CreamDrug: Vehicle
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2022-05-09
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 550
- Registration Number
- NCT01845649
- Locations
- 🇺🇸
Warner Chilcott Investigational Study Site, Spokane, Washington, United States
Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women
- Conditions
- Vulvovaginal Atrophy
- Interventions
- Drug: VehicleDrug: WC3011 Estradiol Vaginal Cream
- First Posted Date
- 2013-03-21
- Last Posted Date
- 2022-05-09
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 576
- Registration Number
- NCT01816139
- Locations
- 🇺🇸
Warner Chilcott Investigational Study Site, Spokane, Washington, United States
Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction
- Conditions
- Erectile Dysfunction
- Interventions
- Drug: WC3036-11F/Alprostadil in Vehicle 2.5%Drug: WC3036-12F/Alprostadil in Vehicle 0.5%Drug: WC3036-13P/Vehicle Only 0.5%
- First Posted Date
- 2013-03-13
- Last Posted Date
- 2014-08-12
- Lead Sponsor
- Warner Chilcott
- Target Recruit Count
- 16
- Registration Number
- NCT01810575
- Locations
- 🇺🇸
Warner Chilcott Investigational Study Site, Purchase, New York, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 12
- Next